Back to Treatments

Treatment

Doxorubicin + Cyclophosphamide + Paclitaxel (AC-T Chemotherapy Regimen)

1
Conditions
21
Trials
150K
Participants
25%
Average Safety

Condition Evidence

Breast cancer

21 trials · 150K participants

80% effectiveness · 25% safety
Doxorubicin + Cyclophosphamide + Paclitaxel (AC-T Chemotherapy Regimen) | DFDA